Aurobindo Pharma reported INR16.58 in EPS Earnings Per Share for its fiscal quarter ending in September of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q2 Sep/2025 19.57 16.56 14.61 Nov/04
FY2026Q1 Jun/2026 17.86 17.08 14.20 Aug/04
FY2026Q4 Mar/2026 15.86 16.04 15.56 May/20
FY2026Q3 Dec/2025 15.67 15.33 14.56 Feb/09
FY2026Q2 Sep/2025 14.61 18.02 16.30 Nov/05




Eps Change Date
Cipla INR 10.85 1.09 Sep/2026
Divis Laboratories Ltd INR 42.49 18.47 Sep/2026
Dr.Reddys Laboratories INR 11.24 5.91 Sep/2026
Hindustan Unilever INR 11.87 0.67 Sep/2026
Sun Pharmaceuticals INR 13.2 0.09 Sep/2026
UPL INR 5 4.88 Sep/2026